Hjem › Mavekreft › California › Orange
Kliniske studier for Mavekreft i Orange, CA
13 studier for Mavekreft søker deltakere på steder i og rundt Orange (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
RekruttererFase 2
- Research Site, Orange
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
RekruttererFase 2/3
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- UC IRVINE Health, Orange
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RekruttererFase 3
- Research Site, Orange
Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)
RekruttererFase 2
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Patient-Derived Xenografts to Reduce Cancer Health Disparities
RekruttererObservasjonsstudie
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekruttererFase 1
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RekruttererFase 2
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Combination of TATE and PD-1 Inhibitor in Liver Cancer
RekruttererFase 2
- University of California, Irvine, Orange
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- Stern Center for Cancer Clinical Trials and Research, Orange
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
RekruttererFase 2
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Orange
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
RekruttererFase 1/2
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Mavekreft-studier i andre byer
- Houston, TX42 studier
- Boston, MA32 studier
- New York City, NY31 studier
- Nashville, TN28 studier
- Baldwin Park, CA22 studier
- Los Angeles, CA22 studier
- Arlington, VA20 studier
- Dallas, TX19 studier
- San Antonio, TX19 studier
- St. Louis, MO18 studier
- Grand Rapids, MI18 studier
- Washington, DC16 studier
Andre studier i Orange
- Ikke-småcellet lungekreft25 studier
- Metastatisk kreft20 studier
- Kolorektal kreft16 studier
- Eggstokkreft16 studier
- Pankreaskreft15 studier
- Melanom14 studier
- Leverkreft (hepatocellulært karcinom)14 studier
- Brystkreft14 studier
- Lungekreft14 studier
- Prostatakreft14 studier
- Kreft (alle typer)13 studier
- Akut myelogen leukemi13 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.